Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Think its important to look at MCAP 56m / Shares in issue 25m, just doing a tiny bit of research looks like they are in bed with Roche with the SARS-CoV-2 testing portfolio. Not invested there but will be good to monitor the appetite and SP rise over there :)
Let them sell, try buying in on release of possible good news, it goes straight into auction and try placing your trade in that frenzy as you get the ask which is determined. With a low amount of share in issue, try guessing that entry SP point? :)
That made me laugh Borgie!! :) share manipulation at its finest yesterday searching for stop losses! I don’t think the drop was manufactured for Hargreaves though, could expect some large TR3s after hours tomorrow evening?
Hamsters, absolutely no idea what the old guard were doing in all honesty?! But Suze definitely brings a breath of fresh air, the material transfer on 301 could be quite interesting as well.
Grace, great post. Would you think that 201 could work in combination with Keytruda for example? I would expect Keytruda - Merck to be sniffing around. Or possibly the Jap that are investigating 301? Imagine a bidding war over it :) As you mention I am expecting better results from 201 than 4D, would we be notified if anyone had passed away during the 201 trial to date? I’m sure from the last set of results there was a mention of someone recovering from treatment so well they were playing golf again?! Can’t remember where I heard that :)
I just keep looking at 4D with their 26 August announcement. Similar trial 12 patients but in combination with Keytruda. 5 patients with a positive reaction. Let’s see what 201 brings on its own, but in combo with another drug such as Keytruda sky is the limit. Also looking forward to what this Jap Pharma evaluation on 301, exciting times.........at long bloody last!! As others have posted great work by Fred, Valju etc also, wouldn’t even be here today without their intervention:)
Thanks RB, didn’t know it had progressed this far in all honesty, great news though. ‘’The therapeutic application dovetails nicely with prognostic biomarker development work being carried out at Volition. Recent positive results from Volition’s first two clinical studies were very encouraging and further prospective studies are planned.’’ Are we collaborating with Voltion RX from the US also?